Eurofins Scientific (ERF) | Stock Overview & Key Data
Eurofins Scientific SE | Large-cap | Healthcare
Eurofins Scientific SE | Large-cap | Healthcare
Eurofins Scientific Performance Comparison
Stock Range
Today's Range
Low: €62.24
High: €63.00
on September 23, 2025
52 Week Range
Low: €44.52
High: €69.40
on November 13, 2024
on July 28, 2025
All-Time High: €620.20 on May 25, 2020
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Market Cap
€11.1B
EPS
2.27
P/E Ratio (TTM)
27.61
Forward P/E
18.06
P/B Ratio
3.25
PEG Ratio
N/A
Div. Yield
1.82%
ROE
8.68%
Beta
0.695
Debt to Equity
88.06
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
13.16%
Profit Margin
6.05%
Returns and Earnings
Return on Assets (TTM)
5.46%
Return on Equity (TTM)
8.68%
EBITDA
€1.4B
Net Income (TTM)
€380.9M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€38.25
Quarterly Revenue Growth (YoY)
5.70%
Quarterly Earnings Growth (YoY)
11.70%
Dividend Information
Last 12-Month Dividend
€1.10
Current Dividend Yield
1.82%
3-Year Average Dividend Yield
1.29%
3-Year Average Annual Dividend
€1.03
3-Year Total Dividends
€3.10
Ex-Dividend Date
April 28, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Eurofins Scientific ERF | 11.14B Large-cap | -0.32% | -6.44% | 4.91% | 23.45% | 28.03% | 7.84% | 2.16% | -10.90% |
| bioMérieux S.A BIM | 13.47B Large-cap | 0.71% | -9.44% | -5.62% | -2.23% | 11.20% | 4.67% | 40.29% | -14.90% |
| Lumibird S.A LBIRD | 453.34M Mid-cap | 3.92% | 12.43% | 23.60% | 91.35% | 107.29% | 134.12% | 33.56% | 92.08% |
| Eurofins Cerep SAS ALECR | 92.80M Small-cap | 0.00% | -1.09% | -11.65% | -11.65% | -7.14% | -14.95% | -18.02% | 54.24% |
| Klea Holding ALKLH | 73.69M Small-cap | 13.64% | 19.05% | 38.89% | 25.00% | 47.06% | 19.05% | 31.58% | 31.58% |
| Predilife S.A ALPRE | 12.12M Small-cap | -1.54% | -1.84% | -13.51% | -16.67% | -10.11% | -34.69% | -46.84% | -52.94% |
Ownership & Short Interest
Insider Ownership
34.87%
Institutional Ownership
37.21%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
253K
Average 90-Day Volume
224K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ERF's 52-week high and low?
- In the last 52 weeks, Eurofins Scientific reached a high of €69.40 (on July 28, 2025) and a low of €44.52 (on November 13, 2024).
- What is the market cap and P/E ratio for ERF?
- Curious about Eurofins Scientific's size and valuation? Its market capitalization stands at 11.14B. When it comes to valuation, the P/E ratio (trailing twelve months) is 27.61, and the forward P/E (looking ahead) is 18.06.
- Does ERF pay dividends? If so, what's the yield?
- Yes, Eurofins Scientific is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.82%, and the company has paid an average of €1.03 per share annually over the past 3 years.
- Who are Eurofins Scientific's main competitors or similar companies to consider before investing?
When looking at Eurofins Scientific, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return bioMérieux S.A
BIM13.47B Healthcare Diagnostics & Research 4.67% 40.29% Lumibird S.A
LBIRD453.34M Healthcare Diagnostics & Research 134.12% 33.56% Eurofins Cerep SAS
ALECR92.80M Healthcare Diagnostics & Research -14.95% -18.02% Klea Holding
ALKLH73.69M Healthcare Diagnostics & Research 19.05% 31.58% Predilife S.A
ALPRE12.12M Healthcare Diagnostics & Research -34.69% -46.84% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Eurofins Scientific SE? (e.g., ROE, Debt/Equity)
- To get a sense of Eurofins Scientific's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 8.68%, the Debt to Equity ratio from the most recent quarter is 88.06, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ERF?
- Looking at Eurofins Scientific's growth, its revenue over the trailing twelve months (TTM) was €7B. Compared to the same quarter last year (YoY), quarterly revenue grew by 5.70%, and quarterly earnings saw a YoY growth of 11.70%.
- How much of ERF stock is held by insiders and institutions?
- Wondering who owns Eurofins Scientific stock? Company insiders (like executives and directors) hold about 34.87% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 37.21%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.